MYND Life Sciences (XCNQ:MYND) Accounts Payable & Accrued Expense : C$3.71 Mil (As of Jul. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences Accounts Payable & Accrued Expense?

MYND Life Sciences's quarterly accounts payable & accrued expense increased from Jan. 2024 (C$3.12 Mil) to Apr. 2024 (C$3.32 Mil) and increased from Apr. 2024 (C$3.32 Mil) to Jul. 2024 (C$3.71 Mil).

MYND Life Sciences's annual accounts payable & accrued expense increased from Oct. 2021 (C$0.29 Mil) to Oct. 2022 (C$1.60 Mil) and increased from Oct. 2022 (C$1.60 Mil) to Oct. 2023 (C$2.78 Mil).

MYND Life Sciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for MYND Life Sciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences Accounts Payable & Accrued Expense Chart

MYND Life Sciences Annual Data

Trend

Oct21

Oct22

Oct23

Accounts Payable & Accrued Expense

0.29

1.60

2.78

MYND Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial										2.84	2.78	3.12	3.32	3.71

MYND Life Sciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

MYND Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

MYNDF:USA

Address

105-2248 Elgin Avenue, Port Coquitlam, BC, CAN, V3C 2B2

Website

https://www.myndsciences.com

MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.